Historical record - last NADAC effective date: 1/5/2016
Product Information
E.E.S. 200 MG/5 ML GRANULES is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $3.1656 per ML under NDC 24338013610. Its NADAC has been published 164 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/5mL
Manufacturer
Azurity Pharmaceuticals Inc.NDC
24338013610
Classification
Brand
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Effective Date
1/5/2016
Active Ingredients
ERYTHROMYCIN ETHYLSUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA050207FDA Approved
Before 1982
TE Code
AB
On Market Since
4/18/2011
Pharmacological Classes
Price Statistics
The NADAC for E.E.S. 200 MG/5 ML GRANULES has been published 164 times since Nov 28, 2013, and over the history we have for it it has risen 293.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1656 per ML |
|---|---|
| All-time high | $3.1656 (Jan 11, 2017) |
| All-time low | $0.8041 (Nov 28, 2013) |
| Median price | $2.4317 |
| Average price | $2.3029 |
| Largest weekly change | +50.0% (Mar 5, 2014) |
| Weeks tracked | 164 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+293.7%
Last surveyed Jan 11, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 71% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of E.E.S. 200 MG/5 ML GRANULES?
The current National Average Drug Acquisition Cost (NADAC) for E.E.S. 200 MG/5 ML GRANULES, manufactured by Azurity Pharmaceuticals Inc., is $3.1656 per ML (NDC 24338013610), effective Jan 11, 2017.
How has the price of E.E.S. 200 MG/5 ML GRANULES changed over time?
Over the history we have for it, the NADAC for E.E.S. 200 MG/5 ML GRANULES has risen 293.7%. It has been tracked across 164 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for E.E.S. 200 MG/5 ML GRANULES?
Since Nov 28, 2013, the NADAC for E.E.S. 200 MG/5 ML GRANULES has ranged from a low of $0.8041 (Nov 28, 2013) to a high of $3.1656 (Jan 11, 2017), with a median of $2.4317 per ML.
Are there cheaper alternatives to E.E.S. 200 MG/5 ML GRANULES?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN 200 MG/5 ML SUSP, is $0.9144 per ML — about 71% below E.E.S. 200 MG/5 ML GRANULES.
Who manufactures E.E.S. 200 MG/5 ML GRANULES?
E.E.S. 200 MG/5 ML GRANULES (NDC 24338013610) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.